Only "Independent Expert’s preferred value of a ResApp share", these T/O are usually "premium" from a big pharma so....
Ann: Pfizer raises scheme consideration to A$0.208 per share, page-3
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
Add to My Watchlist
What is My Watchlist?